Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference209 articles.
1. IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer;Abiko;British Journal of Cancer,2015
2. Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma;Abou-Alfa;NEJM Evidence,2022
3. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma;Abou-Alfa;The New England Journal of Medicine,2018
4. The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma;Agdashian;Cancer Immunology, Immunotherapy,2019
5. Evaluation of immunogenicity of nivolumab monotherapy and its clinical relevance in patients with metastatic solid tumors;Agrawal;Journal of Clinical Pharmacology,2017
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and systematic review;Journal of Cancer Research and Clinical Oncology;2024-02-06
2. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial;Nature Medicine;2024-01-19
3. Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics;Journal of Hepatocellular Carcinoma;2023-12
4. Identification of CERS5 as a novel biomarker for prognosis and immunity in hepatocellular carcinoma: a bioinformatics analysis and functional validation study;2023-11-02
5. IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification;Cell Cycle;2023-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3